Johnson & Johnson (JNJ) Deferred Taxes (2009 - 2026)

Johnson & Johnson has disclosed Deferred Taxes across 18 years of filings, most recently posting -$479.0 million for Q2 2026.

• In Q2 2026, Deferred Taxes fell 158.06% year-over-year to -$479.0 million; the TTM figure through Jun 2026 stood at -$1.8 billion (down 157.93% YoY), while the FY2025 annual figure was $1.5 billion, up 170.45% from the prior year.
• Deferred Taxes came in at -$479.0 million for Q2 2026 at Johnson & Johnson, down from $159.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $2.2 billion in Q3 2025 to a low of -$3.7 billion in Q4 2025.
• Average Deferred Taxes over 5 years is -$324.0 million, with a median of -$247.5 million recorded in 2024.
• The largest YoY upside for Deferred Taxes was 2364.44% in 2025 against a maximum downside of 22881.25% in 2025.
• Over 5 years, Deferred Taxes stood at -$926.0 million in 2022, then tumbled by 160.48% to -$2.4 billion in 2023, then jumped by 99.34% to -$16.0 million in 2024, then plunged by 22881.25% to -$3.7 billion in 2025, then soared by 86.97% to -$479.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$479.0 million in Q2 2026, $159.0 million in Q1 2026, and -$3.7 billion in Q4 2025.